Aragón participa en un estudio internacional que aporta nuevas claves sobre la vacunación contra la COVID-19 en el embarazo y la prevención de la preeclampsia
19 febrero, 2026GILEAD – Research Scholars Program 2026
20 febrero, 2026UCB has 4 areas of interest:
- Immunology
- Neurology
- Rare disease
- Bone disease
The Stef Smith Research Grant focuses on innovative research ideas in the field of myasthenia gravis. (cause, diagnosis or management).
Eligibility criteria:
- Submitted projects should be focused on cause, diagnosis or management of myasthenia gravis
- UCB Pharma will only consider applications submitted by healthcare organizations/institutions
- Funding shall only be provided to an organization, and not to individual recipients
- Research project leads of the project team must hold a Doctor of Medicine (M.D.), or equivalent degree and not be beyond Assistant Professor level, plus not more than 5 years post neurology training
Deadlines:
Letter of Interest (LoI): 28 February 2026
Full proposal: 31 October 2026